TP53 mutation promotes sunitinib resistance in gallbladder cancer via the ARHGEF7-AS2/miR-326/AXL pathway
- DOI
- 10.1016/j.apsb.2026.08.019
- Published
- 2026-11
- Container
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2026.08.019,
title = {TP53 mutation promotes sunitinib resistance in gallbladder cancer via the ARHGEF7-AS2/miR-326/AXL pathway},
author = {Linhua Yang and Ming Zhan and Ruifeng Yang and Miaomiao Guo and Min He and Yixiang Gu and Yang Zhang and Zhilian Jia and Xiaohua Huang and Bingyu Li and Hui Wang and Ruimeng Yang and Yingbin Liu},
year = {2026},
journal = {Acta Pharmaceutica Sinica B},
doi = {10.1016/j.apsb.2026.08.019},
url = {https://doi.org/10.1016/j.apsb.2026.08.019}
}RIS
TY - JOUR TI - TP53 mutation promotes sunitinib resistance in gallbladder cancer via the ARHGEF7-AS2/miR-326/AXL pathway AU - Linhua Yang AU - Ming Zhan AU - Ruifeng Yang AU - Miaomiao Guo AU - Min He AU - Yixiang Gu AU - Yang Zhang AU - Zhilian Jia AU - Xiaohua Huang AU - Bingyu Li AU - Hui Wang AU - Ruimeng Yang AU - Yingbin Liu PY - 2026 JO - Acta Pharmaceutica Sinica B DO - 10.1016/j.apsb.2026.08.019 UR - https://doi.org/10.1016/j.apsb.2026.08.019 ER -
APA
Yang, L., Zhan, M., Yang, R., Guo, M., He, M., Gu, Y., Zhang, Y., Jia, Z., Huang, X., Li, B., Wang, H., Yang, R., & Liu, Y. (2026). TP53 mutation promotes sunitinib resistance in gallbladder cancer via the ARHGEF7-AS2/miR-326/AXL pathway. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.08.019
Source records
- crossref · retrieved 2026-11-08T01:31:20.570Z